Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population- Based Analysis Babatunde A. Yerokun, MD, Zhifei Sun, MD, Chi-Fu Jeffrey.

Slides:

Advertisements

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Advertisements

A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer Babatunde A. Yerokun, MD, Chi-Fu.

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Outcomes of Major Lung Resection After Induction Therapy for Non-Small Cell Lung Cancer in Elderly Patients Chi-Fu Jeffrey Yang, MD, Nicholas R. Mayne,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,

Masatsugu Hamaji, MD, Syed Osman Ali, MD, Bryan M. Burt, MD

Benny Weksler, MD, Jennifer L. Sullivan, MD

Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C

Trevor Williams, MD, MPH, Brian C

Chi-Fu Jeffrey Yang, MD, Derek Y. Chan, BSE, Paul J

Emergent Esophagectomy for Esophageal Perforations: A Safe Option

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Minimally Invasive Versus Sternotomy Approach for Mitral Valve Surgery in Patients Greater Than 70 Years Old: A Propensity-Matched Comparison David M.

How to Keep the Treatment of Esophageal Disease in the Surgeon’s Hands

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Prognostic Value of Different Lymph Node Staging Methods in Esophageal Squamous Cell Carcinoma After Esophagectomy San-Gang Wu, MD, Feng-Yan Li, MD,

Gal Levy, MD, Mark A. Cordes, MD, Alexander S. Farivar, MD, Ralph W

Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery

Lymph Node Evaluation by Open or Video-Assisted Approaches in 11,500 Anatomic Lung Cancer Resections Daniel J. Boffa, MD, Andrzej S. Kosinski, PhD, Subroto.

Robert E. Freundlich, MD, MS, Michael D. Maile, MD, MS, Mark M

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Castigliano M. Bhamidipati, DO, MS, George J

Prognostic Variables in Thoracic Esophageal Squamous Cell Carcinoma

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease Brendon M. Stiles, MD, Farooq Mirza, MD, Anthony Coppolino, MD, Jeffrey L. Port,

Loretta Erhunmwunsee, MD, Brian C

Mark F. Berry, MD, Nestor R. Villamizar-Ortiz, MD, Betty C

Mark D. Iannettoni, MD, William R. Lynch, MD, Kalpaj R

Anthony Lemaire, MD, William R

A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer Brian C. Gulack, MD, Chi-Fu Jeffrey Yang,

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

Trevor Williams, MD, MPH, Brian C

Conditional Cancer-Specific Versus Cardiovascular-Specific Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Shawn S. Groth, MD, MS, Natasha.

Asad A. Shah, MD, Mathias Worni, MD, MHS, Christopher R

Surgical Considerations for the Management and Resection of Esophageal Gastrointestinal Stromal Tumors Matthew G. Blum, MD, Karl Y. Bilimoria, MD, Jeffrey.

Kevin L. Anderson, MHSc, Michael S. Mulvihill, MD, Paul J

Radical Lymph Node Dissection in Primary Esophagectomy for Esophageal Squamous Cell Carcinoma Chen-Sung Lin, MD, PhD, Chih-Tao Cheng, MD, DrPH, Chao-Yu.

Use of Amiodarone After Major Lung Resection

Thomas J. Watson, MD, Jiejing Qiu, MS The Annals of Thoracic Surgery

Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi Filosso, MD, Paraskevas Lyberis,

Comparison of the 6th and 7th Editions of the American Joint Committee on Cancer Tumor-Node-Metastasis Staging System in Patients With Resected Esophageal.

Risk Factors for Atrial Fibrillation After Lung Cancer Surgery: Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database Mark Onaitis,

Brendon M. Stiles, MD, Mohamed K. Kamel, MD, Sebron W

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Patient Preferences in Treatment Choices for Early-Stage Lung Cancer

The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients

Robot-Assisted Minimally Invasive Ivor Lewis Esophagectomy With Real-Time Perfusion Assessment Arielle Hodari, MD, Ko Un Park, MD, Brian Lace, MD, Athanasios.

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

Adjuvant Chemotherapy Is Associated with Improved Survival after Esophagectomy without Induction Therapy for Node-Positive Adenocarcinoma Paul J. Speicher,

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Asvin M. Ganapathi, MD, Paul J. Speicher, MD, Anthony W

Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C

Attila Dubecz, MD, Thomas J. Watson, MD, Daniel P

Acute Esophageal Necrosis: A Case Series and Long-Term Follow-Up

Risk Factors for Local Recurrence and Optimal Length of Esophagectomy in Esophageal Squamous Cell Carcinoma Chang Hyun Kang, MD, PhD, Yoohwa Hwang, MD,

Does the Approach Matter

Specialty Training and Mortality After Esophageal Cancer Resection

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Neal S Goldstein, MD The Annals of Thoracic Surgery

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Survival Benefits of Postoperative Chemoradiation for Lymph Node–Positive Esophageal Squamous Cell Carcinoma Po-Kuei Hsu, MD, Chien-Sheng Huang, MD,

Management of Delayed Gastric Emptying After Esophagectomy With Endoscopic Balloon Dilatation of the Pylorus Michael Lanuti, MD, Pierre DeDelva, MD,

Mark I. Block, MD The Annals of Thoracic Surgery

Lobectomy Versus Limited Resection in T1N0 Lung Cancer

Alexander H. Moskovitz, MD, Nabil P

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Presentation transcript:

Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population- Based Analysis Babatunde A. Yerokun, MD, Zhifei Sun, MD, Chi-Fu Jeffrey Yang, MD, Brian C. Gulack, MD, Paul J. Speicher, MD, Mohamed A. Adam, MD, Thomas A. D’Amico, MD, Mark W. Onaitis, MD, David H. Harpole, MD, Mark F. Berry, MD, Matthew G. Hartwig, MD The Annals of Thoracic Surgery Volume 102, Issue 2, Pages 416-423 (August 2016) DOI: 10.1016/j.athoracsur.2016.02.078 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Forest plot of factors associated with use of minimally invasive esophagectomy (MIE). Black squares represent odds ratios for the independent association of each factor with using MIE; 95% confidence interval bounds are represented by the corresponding horizontal lines. Factors to the right of the vertical line at 1.0 are independently associated with using MIE. Patients receiving care at an academic or comprehensive institution are associated with use of minimally invasive esophagectomies, whereas patients with cT2 and cT3 tumors were associated with use of open esophagectomy (OE). The Annals of Thoracic Surgery 2016 102, 416-423DOI: (10.1016/j.athoracsur.2016.02.078) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Survival of open esophagectomy (OE) versus minimally invasive esophagectomy (MIE) and standard minimally invasive esophagectomy (SMIE) versus robotic-assisted minimally invasive esophagectomy (RAMIE), stratified by histologic type. (A) Adenocarcinoma: OE versus MIE; (B) adenocarcinoma: SMIE versus RAMIE; (C) squamous cell carcinoma: OE versus MIE; (D) squamous cell carcinoma: SMIE versus RAMIE. The Annals of Thoracic Surgery 2016 102, 416-423DOI: (10.1016/j.athoracsur.2016.02.078) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions